Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | AGXT | P21549 | 2/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL988626 | 0.90 | AGXT (0.43) | ESR1IDO1CA2AGXTTAAR1 | |
| SCHEMBL3099832 | 0.90 | TP53 (0.40) | CA2TAAR1ATMTSHRALDH1A1 | |
| SCHEMBL15444222 | 0.88 | CA1 (0.34) | ESR1CA2 | |
| SCHEMBL17529722 | 0.88 | APP (0.42) | IDO1CYP3A4 | |
| SCHEMBL938705 | 0.88 | TAAR1 (0.43) | IDO1AGXTTAAR1POLBALDH1A1 | |
| SCHEMBL17529660 | 0.88 | ESR1 (0.32) | ESR1 | |
| SCHEMBL17529742 | 0.88 | TAAR1 (0.43) | IDO1TAAR1ALDH1A1 | |
| SCHEMBL16062869 | 0.88 | ESR1 (0.37) | ESR1 | |
| SCHEMBL3361270 | 0.88 | ESR1 (0.32) | ESR1 | |
| SCHEMBL15734527 | 0.88 | TAAR1 (0.43) | IDO1AGXTTAAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4569015-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | Promega Corporation (US) | 2025-06-18 | — | — | EP | claimed |
| US-20240059961-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | PROMEGA CORPORATION | 2024-02-22 | — | — | US | claimed |
| WO-2024036277-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | PROMEGA CORPORATION (US) | 2024-02-15 | — | — | WO | claimed |
| CN-117343638-A | Porous spin-on dielectric coating materials from silicon-containing polymers | 上海艾深斯科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2022261559-A9 | ANTIFOULING MATERIALS, COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2023-11-30 | — | — | WO | claimed |
| EP-2739670-B1 | SOL-GEL DERIVED COMPOSITIONS | ABS MAT INC (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2022261559-A2 | ANTIFOULING MATERIALS, COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2022-12-15 | — | — | WO | claimed |
| CN-110756131-B | Flexible hollow mesoporous organic silicon oxide with oleophilic inner surface and preparation method thereof | 吉林大学第一医院 | 2022-02-01 | — | — | CN | claimed |
| US-11162000-B2 | Ice release coatings | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2021-11-02 | — | — | US | claimed |
| US-10934504-B2 | Laundry treatment compositions comprising perfume and silica microparticles | CONOPCO, INC. (US) | 2021-03-02 | — | — | US | claimed |
| US-20070112242-A1 | SWELLABLE SOL-GELS, METHODS OF MAKING, AND USE THEREOF | THE COLLEGE OF WOOSTER (US) | 2007-05-17 | — | — | US | claimed |
| WO-2007040856-A2 | PLASMA-ASSISTED VAPOR PHASE TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040834-A2 | PLURAL TREATMENT STEP PROCESS FOR TREATING DIELECTRIC FILMS | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040816-A2 | TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| US-20070077782-A1 | Treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077353-A1 | Plasma-assisted vapor phase treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077781-A1 | Plural treatment step process for treating dielectric films | TOKYO ELECTRON LIMTED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070059211-A1 | TNT sensor containing molecularly imprinted sol gel-derived films | THE COLLEGE OF WOOSTER (US) | 2007-03-15 | — | — | US | claimed |
| WO-2006091264-A1 | METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM | TOKYO ELECTRON LIMITED (JP) | 2006-08-31 | — | — | WO | claimed |
| US-20050215072-A1 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2005-09-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059961-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | COXFA4L2, LOXL1, LOX | ESR1 1005/4885IDO1 1235/4885CA2 643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.